CANbridge certified Golden Seed Enterprise by Administrative Committee of Zhongguancun Science Park
CANbridge has been certified Golden Seed Enterprise by Administrative Committee of Zhongguancun Science Park.
Golden Seed Project was created in 2011 to recognize up-and-coming innovation companies with high potential to make an impact in strategic and emerging industry sectors.
For more information, pls contact firstname.lastname@example.org
About CANbridge Life Sciences
CANbridge Life Sciences, Ltd. is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare products for serious and critical medical conditions in China and North Asia (Korea and Taiwan).CANbridge develops partnerships with Western bio-pharmaceutical companies with clinical-stage pharmaceutical, medical device or diagnostic products that are either unavailable in China/North Asia or address medical needs that are underserved in the region. CANbridge also licenses or obtains exclusive rights to commercialize drug and device products that are approved in their home markets, for commercialization in China and North Asia.
Led and backed by a highly-seasoned executive team, with extensive Chinese drug development experience, CANbridge has the capability to select, acquire, develop and commercialize future therapeutics and diagnostics targeting the unmet medical needs of Chinese and East Asian patients with serious or critical conditions.
CANbridge is privately-held and headquartered in Beijing, China. For more on CANbridge Life Sciences, please go to www.canbridgepharma.com.